| Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome MDM Noblejas-López, C Nieto-Jiménez, S Morcillo Garcia, J Pérez-Peña, ... Oncoimmunology 8 (10), e1629780, 2019 | 41 | 2019 |
| Functional transcriptomic annotation and protein–protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A … M Nuncia-Cantarero, S Martinez-Canales, F Andrés-Pretel, G Santpere, ... Breast cancer research and treatment 168, 613-623, 2018 | 41 | 2018 |
| Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors S Morcillo-Garcia, MM Noblejas-Lopez, C Nieto-Jimenez, J Perez-Peña, ... PLoS One 14 (4), e0209134, 2019 | 17 | 2019 |
| Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene MM Noblejas-López, S Morcillo-Garcia, C Nieto-Jiménez, ... PloS one 13 (11), e0207776, 2018 | 17 | 2018 |
| Functional transcriptomic annotation and protein–protein interaction analysis identify EZH 2 and UBE 2C as key upregulated proteins in ovarian cancer S Martínez‐Canales, M Lopez de Rodas, M Nuncia‐Cantarero, R Páez, ... Cancer medicine 7 (5), 1896-1907, 2018 | 16 | 2018 |
| Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer L Serrano-Oviedo, M Nuncia-Cantarero, S Morcillo-Garcia, ... Cellular Oncology 43, 431-444, 2020 | 13 | 2020 |
| Checkpoint kinase 1 pharmacological inhibition synergizes with DNA-damaging agents and overcomes platinum resistance in basal-like breast cancer C Nieto-Jimenez, A Alcaraz-Sanabria, S Martinez-Canales, ... International Journal of Molecular Sciences 21 (23), 9034, 2020 | 7 | 2020 |
| Characterization of permeability barrier dysfunction in a murine model of cutaneous field cancerization following chronic UV-B irradiation: Implications for the pathogenesis of … JL Santiago, JR Muñoz-Rodriguez, MA Cruz-Morcillo, C Villar-Rodriguez, ... Cancers 13 (16), 3935, 2021 | 6 | 2021 |
| Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer. M Nuncia Cantarero, L Serrano-Oviedo, C Nieto Jimenez, D Tebar Garcia, ... Journal of Clinical Oncology 38 (15_suppl), e13098-e13098, 2020 | 1 | 2020 |
| Epigenetic mutational landscape in breast cancer: role of the histone methyltransferase gene KMT2D in triple negative tumors SM García, MM Noblejas-López, C Nieto-Jiménez, J Perez-Peña, ... bioRxiv, 486233, 2018 | 1 | 2018 |
| Evaluación de nuevas estrategias terapéuticas dirigidas al nicho tumoral en cáncer de mama triple negativo M Nuncia Cantarero Evaluación de nuevas estrategias terapéuticas dirigidas al nicho tumoral en …, 2021 | | 2021 |
| Expression of MHC class I, HLA-A and HLA-B identifies immune activated breast tumours with favorable outcome MDM Noblejas Lopez, C Nieto-Jimenez, S Morcillo-Garcia, J Perez-Pena, ... ANNALS OF ONCOLOGY 30, 515-515, 2019 | | 2019 |
| The tyrosine kinase inhibitor dasatinib blocks tumour growth, invasion and recurrence potential by interrupting the communication between cancer cells and their surrounding … M Nuncia-Cantarero, C Nieto-Jiménez, M Burgos, JC Montero, A Ocaña, ... Annals of Oncology 30, v10, 2019 | | 2019 |
| Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer EM Galan-Moya, M Nuncia-Cantarero, L Serrano-Oviedo, ... Annals of Oncology 30, v782, 2019 | | 2019 |
| Pharmacologic screening identifies synthetic lethality interactions with Chk1 inhibitors in basal-like breast and ovarian cancer EM Galan-Moya, A Alcaraz-Sanabria, C Nieto-Jimenez, ... Cancer Research 78 (13_Supplement), 1608-1608, 2018 | | 2018 |
